Melatonina Biofarm

Melatonin, the active ingredient in Melatonina Biofarm, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate sleep patterns in adults experiencing insomnia or jet lag.

GNH USA supplies Melatonina Biofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonina Biofarm, a melatonin receptor agonist, is used to address sleep‑related disorders.

- Insomnia: helps reduce time to fall asleep and improve sleep continuity. - Jet lag: assists in adjusting the circadian rhythm after rapid time‑zone travel.

Melatonina Biofarm may cause a range of adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects: - Drowsiness - Headache - Dizziness - Nausea - Vivid dreams - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling) - Mood changes or depression - Severe hypotension - Hallucinations - Persistent daytime sleepiness

When considering Melatonina Biofarm, several safety measures should be observed.

- Assess renal or hepatic impairment: adjust use if organ dysfunction is present. - Avoid operating machinery: possible residual drowsiness may impair alertness. - Consult a healthcare professional if pregnant or breastfeeding: safety data are limited. - Review concomitant sedatives: combined use may enhance central nervous system depression. - Store at room temperature: keep in the original container, protect from moisture and light.

Melatonina Biofarm can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): melatonin may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may alter drug levels. - Central nervous system depressants (e.g., benzodiazepines): can intensify sedation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: melatonin may reduce contraceptive efficacy. - Antidepressants (SSRIs, SNRIs): potential for increased serotonergic effects. - Caffeine: may diminish melatonin’s sleep‑promoting action.